Look behind the lecture: Gurpreet Singh delves into machine learning in drug discovery

In this interview, we sit down with Gurpreet Singh, Head of Applied Machine Learning at Bayer (Leverkusen, Germany), to explore his talk on machine learning presented at the AI & Machine Learning in Drug Discovery & Development Summit (5–7 July 2022, virtual). Gurpreet shares his insights on AI in therapeutic target identification, the impact of AI in drug repositioning and much more in an interview not to be missed. What sparked your interest in AI in medicine and how has the field progressed since? The capacity of these algorithms to manage vast, multidimensional datasets sparked my interest in artificial intelligence....